Picilorex
Chemical compound
- None
- 3-(4-Chlorophenyl)-5-cyclopropyl-2-methylpyrrolidine
- 62510-56-9
- 191657
- 166413
- S8K2JDR3NZ
- Interactive image
- CC1C(CC(N1)C2CC2)c3ccc(cc3)Cl
InChI
- InChI=1S/C14H18ClN/c1-9-13(8-14(16-9)11-2-3-11)10-4-6-12(15)7-5-10/h4-7,9,11,13-14,16H,2-3,8H2,1H3
- Key:PZJBWSQQDMRZHY-UHFFFAOYSA-N
Picilorex (INN; brand name Roxenan; IUPAC: 3-(4-Chlorophenyl)-5-cyclopropyl-2-methylpyrrolidine)[1] is an anorectic which is no longer marketed.[2][3][4] It is a monoamine reuptake inhibitor, a stimulant as well as a derivate of Pyrrolidine.[3]
See also
- α-PHP
- α-PHPP
- Pyrovalerone
- Prolintane
- Rolicyclidine (PCPy)
- MDPV
- List of aminorex analogues
- Substituted phenylmorpholine
References
- ^ PubChem. "Cyclopropyl-2 p-chlorophenyl-4 methyl-5 pyrrolidine succinate". pubchem.ncbi.nlm.nih.gov. Archived from the original on 2021-05-31. Retrieved 2021-05-31.
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1599–. ISBN 978-0-412-46630-4.
- ^ a b Milne GW (1 January 2001). Ashgate Handbook of Autonomic Nervous System Agents. Wiley. ISBN 978-0-566-08384-6.
- ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0. Archived from the original on 2019-07-14. Retrieved 2016-10-16.
- v
- t
- e
antagonists
glucagon agonists
receptor agonists
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
